nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—breast cancer—Betamethasone—psoriasis	0.181	0.5	CpDpCtD
Ethinyl Estradiol—breast cancer—Dexamethasone—psoriasis	0.181	0.5	CpDpCtD
Ethinyl Estradiol—SLC10A1—Cyclosporine—psoriasis	0.0475	0.149	CbGbCtD
Ethinyl Estradiol—Levonorgestrel—Hydrocortisone—psoriasis	0.0391	0.189	CrCrCtD
Ethinyl Estradiol—Danazol—Hydrocortisone—psoriasis	0.0361	0.174	CrCrCtD
Ethinyl Estradiol—SHBG—Hydrocortisone—psoriasis	0.0334	0.105	CbGbCtD
Ethinyl Estradiol—Norethindrone—Hydrocortisone—psoriasis	0.0314	0.151	CrCrCtD
Ethinyl Estradiol—Danazol—Prednisone—psoriasis	0.0311	0.15	CrCrCtD
Ethinyl Estradiol—Methyltestosterone—Hydrocortisone—psoriasis	0.0258	0.124	CrCrCtD
Ethinyl Estradiol—ABCB11—Cyclosporine—psoriasis	0.0228	0.0717	CbGbCtD
Ethinyl Estradiol—Methyltestosterone—Prednisone—psoriasis	0.0222	0.107	CrCrCtD
Ethinyl Estradiol—Methyltestosterone—Prednisolone—psoriasis	0.0217	0.104	CrCrCtD
Ethinyl Estradiol—AOX1—Methotrexate—psoriasis	0.021	0.0661	CbGbCtD
Ethinyl Estradiol—CYP2C8—Tazarotene—psoriasis	0.0206	0.0647	CbGbCtD
Ethinyl Estradiol—ABCC2—Mycophenolate mofetil—psoriasis	0.0158	0.0497	CbGbCtD
Ethinyl Estradiol—ABCB11—Dexamethasone—psoriasis	0.015	0.0472	CbGbCtD
Ethinyl Estradiol—ABCC2—Cyclosporine—psoriasis	0.012	0.0377	CbGbCtD
Ethinyl Estradiol—CYP2B6—Cholecalciferol—psoriasis	0.0116	0.0365	CbGbCtD
Ethinyl Estradiol—CYP2C8—Cholecalciferol—psoriasis	0.0088	0.0276	CbGbCtD
Ethinyl Estradiol—ABCC2—Dexamethasone—psoriasis	0.00791	0.0248	CbGbCtD
Ethinyl Estradiol—CYP2C8—Mycophenolate mofetil—psoriasis	0.00763	0.024	CbGbCtD
Ethinyl Estradiol—CYP3A4—Calcitriol—psoriasis	0.00693	0.0218	CbGbCtD
Ethinyl Estradiol—ABCC2—Methotrexate—psoriasis	0.00635	0.02	CbGbCtD
Ethinyl Estradiol—CYP2C8—Hydrocortisone—psoriasis	0.00612	0.0192	CbGbCtD
Ethinyl Estradiol—CYP2C8—Cyclosporine—psoriasis	0.00578	0.0182	CbGbCtD
Ethinyl Estradiol—CYP3A4—Methoxsalen—psoriasis	0.00539	0.0169	CbGbCtD
Ethinyl Estradiol—ABCB1—Mycophenolate mofetil—psoriasis	0.00517	0.0162	CbGbCtD
Ethinyl Estradiol—CYP2B6—Dexamethasone—psoriasis	0.00503	0.0158	CbGbCtD
Ethinyl Estradiol—ABCB1—Betamethasone—psoriasis	0.00443	0.0139	CbGbCtD
Ethinyl Estradiol—ABCB1—Prednisolone—psoriasis	0.00437	0.0137	CbGbCtD
Ethinyl Estradiol—ABCB1—Hydrocortisone—psoriasis	0.00414	0.013	CbGbCtD
Ethinyl Estradiol—ABCB1—Prednisone—psoriasis	0.00413	0.013	CbGbCtD
Ethinyl Estradiol—ABCB1—Cyclosporine—psoriasis	0.00391	0.0123	CbGbCtD
Ethinyl Estradiol—CYP2C8—Dexamethasone—psoriasis	0.00381	0.012	CbGbCtD
Ethinyl Estradiol—CYP3A4—Cholecalciferol—psoriasis	0.00357	0.0112	CbGbCtD
Ethinyl Estradiol—CYP3A4—Mycophenolate mofetil—psoriasis	0.00309	0.00972	CbGbCtD
Ethinyl Estradiol—CYP3A4—Triamcinolone—psoriasis	0.00309	0.00972	CbGbCtD
Ethinyl Estradiol—CYP3A4—Betamethasone—psoriasis	0.00266	0.00834	CbGbCtD
Ethinyl Estradiol—CYP3A4—Prednisolone—psoriasis	0.00262	0.00823	CbGbCtD
Ethinyl Estradiol—ABCB1—Dexamethasone—psoriasis	0.00258	0.00809	CbGbCtD
Ethinyl Estradiol—CYP3A4—Hydrocortisone—psoriasis	0.00248	0.0078	CbGbCtD
Ethinyl Estradiol—CYP3A4—Prednisone—psoriasis	0.00247	0.00777	CbGbCtD
Ethinyl Estradiol—CYP3A4—Cyclosporine—psoriasis	0.00235	0.00736	CbGbCtD
Ethinyl Estradiol—ABCB1—Methotrexate—psoriasis	0.00207	0.0065	CbGbCtD
Ethinyl Estradiol—CYP3A4—Dexamethasone—psoriasis	0.00154	0.00485	CbGbCtD
Ethinyl Estradiol—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.000521	0.027	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000441	0.0229	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00039	0.0202	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Nuclear Receptors—VDR—psoriasis	0.000357	0.0185	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000357	0.0185	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL22—psoriasis	0.000308	0.016	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Ovarian Infertility Genes—VDR—psoriasis	0.000288	0.0149	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000282	0.0146	CbGpPWpGaD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—IL23A—psoriasis	0.000272	0.0141	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000272	0.0141	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000271	0.0141	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Nuclear Receptors—VDR—psoriasis	0.000251	0.013	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Nuclear Receptors—PPARG—psoriasis	0.000249	0.0129	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Tryptophan metabolism—CAT—psoriasis	0.000242	0.0125	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000237	0.0123	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000216	0.0112	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000213	0.0111	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000205	0.0106	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000199	0.0103	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000197	0.0102	CbGpPWpGaD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—TGFA—psoriasis	0.000196	0.0101	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000183	0.00949	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000181	0.00936	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000175	0.00909	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Nuclear Receptors—PPARG—psoriasis	0.000175	0.00908	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.00016	0.00829	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000156	0.00808	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.00015	0.00779	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000148	0.00769	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Estrogen Receptor Pathway—JUN—psoriasis	0.000148	0.00766	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	0.000147	0.00762	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000143	0.00741	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000138	0.00717	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000136	0.00706	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000128	0.00662	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000128	0.00661	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Nuclear Receptors—VDR—psoriasis	0.000127	0.00657	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—IL13—psoriasis	0.000126	0.00654	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—REL—psoriasis	0.000125	0.00648	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—TARS—psoriasis	0.000125	0.00647	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000109	0.00566	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000109	0.00563	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	0.000101	0.00523	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Nuclear Receptor transcription pathway—VDR—psoriasis	0.0001	0.00519	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.94e-05	0.00515	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	9.83e-05	0.00509	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	9.7e-05	0.00503	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Estrogen signaling pathway—JUN—psoriasis	9.36e-05	0.00485	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Biological oxidations—CYP2S1—psoriasis	9.32e-05	0.00483	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	9.19e-05	0.00476	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Estrogen signaling pathway—NFKB1—psoriasis	9.01e-05	0.00467	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Nuclear Receptors—PPARG—psoriasis	8.83e-05	0.00458	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—TARS—psoriasis	8.79e-05	0.00455	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	8.19e-05	0.00424	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Generic Transcription Pathway—CARM1—psoriasis	8.16e-05	0.00423	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—NRF2 pathway—TGFA—psoriasis	8.14e-05	0.00422	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	7.97e-05	0.00413	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—IL10—psoriasis	7.9e-05	0.00409	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Biological oxidations—CYP2S1—psoriasis	7.89e-05	0.00409	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	7.86e-05	0.00407	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	7.78e-05	0.00403	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.58e-05	0.00393	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	7.57e-05	0.00392	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—IL10—psoriasis	7.56e-05	0.00392	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	7.41e-05	0.00384	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—IL4—psoriasis	7.36e-05	0.00381	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.33e-05	0.0038	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Nuclear Receptor transcription pathway—PPARG—psoriasis	6.98e-05	0.00362	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.93e-05	0.00359	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	6.92e-05	0.00358	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	6.73e-05	0.00349	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	6.69e-05	0.00347	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—HLA-A—psoriasis	6.66e-05	0.00345	CbGpPWpGaD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—NOS2—psoriasis	6.65e-05	0.00344	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—NDUFA5—psoriasis	6.56e-05	0.0034	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	6.13e-05	0.00318	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.12e-05	0.00317	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—LEP—psoriasis	5.89e-05	0.00305	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—HLA-C—psoriasis	5.84e-05	0.00303	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL13—psoriasis	5.81e-05	0.00301	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—CARM1—psoriasis	5.75e-05	0.00298	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—NDUFA5—psoriasis	5.64e-05	0.00292	CbGpPWpGaD
Ethinyl Estradiol—Eye disorder—Betamethasone—psoriasis	5.63e-05	0.000611	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Dexamethasone—psoriasis	5.63e-05	0.000611	CcSEcCtD
Ethinyl Estradiol—Angioedema—Hydrocortisone—psoriasis	5.61e-05	0.000609	CcSEcCtD
Ethinyl Estradiol—Infection—Cyclosporine—psoriasis	5.6e-05	0.000608	CcSEcCtD
Ethinyl Estradiol—Back pain—Triamcinolone—psoriasis	5.59e-05	0.000607	CcSEcCtD
Ethinyl Estradiol—SLC10A1—Metabolism—CYP2S1—psoriasis	5.58e-05	0.00289	CbGpPWpGaD
Ethinyl Estradiol—ESR1—FOXA1 transcription factor network—JUN—psoriasis	5.57e-05	0.00289	CbGpPWpGaD
Ethinyl Estradiol—Malaise—Hydrocortisone—psoriasis	5.54e-05	0.000601	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Cyclosporine—psoriasis	5.53e-05	0.0006	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Mycophenolic acid—psoriasis	5.51e-05	0.000598	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Mycophenolic acid—psoriasis	5.51e-05	0.000598	CcSEcCtD
Ethinyl Estradiol—Dizziness—Hydroxyurea—psoriasis	5.5e-05	0.000597	CcSEcCtD
Ethinyl Estradiol—Oedema—Mycophenolate mofetil—psoriasis	5.5e-05	0.000597	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Cyclosporine—psoriasis	5.48e-05	0.000595	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Betamethasone—psoriasis	5.47e-05	0.000593	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Dexamethasone—psoriasis	5.47e-05	0.000593	CcSEcCtD
Ethinyl Estradiol—Infection—Mycophenolate mofetil—psoriasis	5.47e-05	0.000593	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Mycophenolate mofetil—psoriasis	5.39e-05	0.000586	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Triamcinolone—psoriasis	5.36e-05	0.000582	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Mycophenolate mofetil—psoriasis	5.34e-05	0.00058	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL17A—psoriasis	5.34e-05	0.00277	CbGpPWpGaD
Ethinyl Estradiol—Alopecia—Betamethasone—psoriasis	5.33e-05	0.000578	CcSEcCtD
Ethinyl Estradiol—Alopecia—Dexamethasone—psoriasis	5.33e-05	0.000578	CcSEcCtD
Ethinyl Estradiol—Vomiting—Hydroxyurea—psoriasis	5.29e-05	0.000574	CcSEcCtD
Ethinyl Estradiol—Discomfort—Prednisolone—psoriasis	5.29e-05	0.000574	CcSEcCtD
Ethinyl Estradiol—Angioedema—Triamcinolone—psoriasis	5.28e-05	0.000573	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Prednisone—psoriasis	5.28e-05	0.000573	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Prednisone—psoriasis	5.25e-05	0.00057	CcSEcCtD
Ethinyl Estradiol—Rash—Hydroxyurea—psoriasis	5.25e-05	0.00057	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Hydroxyurea—psoriasis	5.24e-05	0.000569	CcSEcCtD
Ethinyl Estradiol—Malaise—Triamcinolone—psoriasis	5.21e-05	0.000566	CcSEcCtD
Ethinyl Estradiol—Headache—Hydroxyurea—psoriasis	5.21e-05	0.000566	CcSEcCtD
Ethinyl Estradiol—Anxiety—Hydrocortisone—psoriasis	5.21e-05	0.000565	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	5.19e-05	0.000564	CcSEcCtD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	5.18e-05	0.00268	CbGpPWpGaD
Ethinyl Estradiol—Discomfort—Hydrocortisone—psoriasis	5.17e-05	0.000561	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Prednisone—psoriasis	5.16e-05	0.00056	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	5.15e-05	0.00267	CbGpPWpGaD
Ethinyl Estradiol—Oedema—Prednisolone—psoriasis	5.13e-05	0.000557	CcSEcCtD
Ethinyl Estradiol—Dysuria—Methotrexate—psoriasis	5.12e-05	0.000556	CcSEcCtD
Ethinyl Estradiol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.11e-05	0.00265	CbGpPWpGaD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—IFNG—psoriasis	5.1e-05	0.00264	CbGpPWpGaD
Ethinyl Estradiol—Upper respiratory tract infection—Methotrexate—psoriasis	5.09e-05	0.000553	CcSEcCtD
Ethinyl Estradiol—Cough—Triamcinolone—psoriasis	5.05e-05	0.000548	CcSEcCtD
Ethinyl Estradiol—Oedema—Hydrocortisone—psoriasis	5.01e-05	0.000544	CcSEcCtD
Ethinyl Estradiol—Asthenia—Mycophenolic acid—psoriasis	5e-05	0.000543	CcSEcCtD
Ethinyl Estradiol—Infection—Hydrocortisone—psoriasis	4.98e-05	0.00054	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL12B—psoriasis	4.97e-05	0.00257	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Hydroxyurea—psoriasis	4.94e-05	0.000537	CcSEcCtD
Ethinyl Estradiol—Pruritus—Mycophenolic acid—psoriasis	4.93e-05	0.000535	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Hydrocortisone—psoriasis	4.91e-05	0.000533	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Prednisone—psoriasis	4.9e-05	0.000532	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Methotrexate—psoriasis	4.89e-05	0.00053	CcSEcCtD
Ethinyl Estradiol—Infestation—Methotrexate—psoriasis	4.89e-05	0.00053	CcSEcCtD
Ethinyl Estradiol—NR1I2—Generic Transcription Pathway—VDR—psoriasis	4.87e-05	0.00253	CbGpPWpGaD
Ethinyl Estradiol—Depression—Methotrexate—psoriasis	4.87e-05	0.000529	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Cyclosporine—psoriasis	4.87e-05	0.000528	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Hydrocortisone—psoriasis	4.87e-05	0.000528	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Betamethasone—psoriasis	4.87e-05	0.000528	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Dexamethasone—psoriasis	4.87e-05	0.000528	CcSEcCtD
Ethinyl Estradiol—Discomfort—Triamcinolone—psoriasis	4.86e-05	0.000528	CcSEcCtD
Ethinyl Estradiol—Fatigue—Cyclosporine—psoriasis	4.86e-05	0.000528	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—HLA-E—psoriasis	4.85e-05	0.00251	CbGpPWpGaD
Ethinyl Estradiol—Constipation—Cyclosporine—psoriasis	4.82e-05	0.000523	CcSEcCtD
Ethinyl Estradiol—AOX1—Metabolism—CYP2S1—psoriasis	4.8e-05	0.00249	CbGpPWpGaD
Ethinyl Estradiol—Angioedema—Dexamethasone—psoriasis	4.79e-05	0.00052	CcSEcCtD
Ethinyl Estradiol—Angioedema—Betamethasone—psoriasis	4.79e-05	0.00052	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Mycophenolic acid—psoriasis	4.77e-05	0.000518	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Prednisone—psoriasis	4.76e-05	0.000517	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	4.75e-05	0.000515	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Prednisone—psoriasis	4.74e-05	0.000515	CcSEcCtD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—CXCL8—psoriasis	4.74e-05	0.00246	CbGpPWpGaD
Ethinyl Estradiol—Malaise—Dexamethasone—psoriasis	4.73e-05	0.000514	CcSEcCtD
Ethinyl Estradiol—Malaise—Betamethasone—psoriasis	4.73e-05	0.000514	CcSEcCtD
Ethinyl Estradiol—Oedema—Triamcinolone—psoriasis	4.72e-05	0.000512	CcSEcCtD
Ethinyl Estradiol—Constipation—Mycophenolate mofetil—psoriasis	4.7e-05	0.000511	CcSEcCtD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	4.7e-05	0.00243	CbGpPWpGaD
Ethinyl Estradiol—Infection—Triamcinolone—psoriasis	4.69e-05	0.000509	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Cyclosporine—psoriasis	4.65e-05	0.000504	CcSEcCtD
Ethinyl Estradiol—Alopecia—Prednisone—psoriasis	4.64e-05	0.000503	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Cyclosporine—psoriasis	4.61e-05	0.0005	CcSEcCtD
Ethinyl Estradiol—Dizziness—Mycophenolic acid—psoriasis	4.61e-05	0.0005	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Prednisone—psoriasis	4.6e-05	0.000499	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Prednisone—psoriasis	4.57e-05	0.000496	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—IFNG—psoriasis	4.55e-05	0.00236	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Mycophenolate mofetil—psoriasis	4.53e-05	0.000492	CcSEcCtD
Ethinyl Estradiol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	4.52e-05	0.00234	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	4.5e-05	0.000488	CcSEcCtD
Ethinyl Estradiol—Urticaria—Cyclosporine—psoriasis	4.48e-05	0.000486	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Cyclosporine—psoriasis	4.46e-05	0.000484	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Cyclosporine—psoriasis	4.46e-05	0.000484	CcSEcCtD
Ethinyl Estradiol—Anxiety—Dexamethasone—psoriasis	4.45e-05	0.000483	CcSEcCtD
Ethinyl Estradiol—Anxiety—Betamethasone—psoriasis	4.45e-05	0.000483	CcSEcCtD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—IFNG—psoriasis	4.45e-05	0.0023	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—TARS—psoriasis	4.43e-05	0.0023	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Mycophenolic acid—psoriasis	4.43e-05	0.000481	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	4.42e-05	0.00229	CbGpPWpGaD
Ethinyl Estradiol—Discomfort—Betamethasone—psoriasis	4.41e-05	0.000479	CcSEcCtD
Ethinyl Estradiol—Discomfort—Dexamethasone—psoriasis	4.41e-05	0.000479	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Methotrexate—psoriasis	4.41e-05	0.000478	CcSEcCtD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—JUN—psoriasis	4.41e-05	0.00228	CbGpPWpGaD
Ethinyl Estradiol—Rash—Mycophenolic acid—psoriasis	4.4e-05	0.000477	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Mycophenolic acid—psoriasis	4.39e-05	0.000477	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Methotrexate—psoriasis	4.39e-05	0.000476	CcSEcCtD
Ethinyl Estradiol—Urticaria—Mycophenolate mofetil—psoriasis	4.37e-05	0.000474	CcSEcCtD
Ethinyl Estradiol—Headache—Mycophenolic acid—psoriasis	4.37e-05	0.000474	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Methotrexate—psoriasis	4.35e-05	0.000473	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Mycophenolate mofetil—psoriasis	4.35e-05	0.000472	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Mycophenolate mofetil—psoriasis	4.35e-05	0.000472	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Methotrexate—psoriasis	4.33e-05	0.00047	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Hydrocortisone—psoriasis	4.33e-05	0.00047	CcSEcCtD
Ethinyl Estradiol—Fatigue—Hydrocortisone—psoriasis	4.32e-05	0.000469	CcSEcCtD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—CXCL8—psoriasis	4.32e-05	0.00224	CbGpPWpGaD
Ethinyl Estradiol—Urethral disorder—Methotrexate—psoriasis	4.3e-05	0.000467	CcSEcCtD
Ethinyl Estradiol—Oedema—Dexamethasone—psoriasis	4.28e-05	0.000465	CcSEcCtD
Ethinyl Estradiol—Oedema—Betamethasone—psoriasis	4.28e-05	0.000465	CcSEcCtD
Ethinyl Estradiol—Infection—Betamethasone—psoriasis	4.25e-05	0.000462	CcSEcCtD
Ethinyl Estradiol—Infection—Dexamethasone—psoriasis	4.25e-05	0.000462	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Prednisone—psoriasis	4.24e-05	0.00046	CcSEcCtD
Ethinyl Estradiol—CYP3A4—Biological oxidations—CYP2S1—psoriasis	4.23e-05	0.00219	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Prednisolone—psoriasis	4.23e-05	0.000459	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Methotrexate—psoriasis	4.23e-05	0.000459	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Betamethasone—psoriasis	4.2e-05	0.000456	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Dexamethasone—psoriasis	4.2e-05	0.000456	CcSEcCtD
Ethinyl Estradiol—Angioedema—Prednisone—psoriasis	4.17e-05	0.000453	CcSEcCtD
Ethinyl Estradiol—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	4.17e-05	0.00216	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Cyclosporine—psoriasis	4.15e-05	0.000451	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Methotrexate—psoriasis	4.15e-05	0.00045	CcSEcCtD
Ethinyl Estradiol—Nausea—Mycophenolic acid—psoriasis	4.14e-05	0.000449	CcSEcCtD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—CXCL8—psoriasis	4.13e-05	0.00214	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Hydrocortisone—psoriasis	4.13e-05	0.000448	CcSEcCtD
Ethinyl Estradiol—ESR1—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	4.13e-05	0.00214	CbGpPWpGaD
Ethinyl Estradiol—Malaise—Prednisone—psoriasis	4.12e-05	0.000447	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Methotrexate—psoriasis	4.1e-05	0.000445	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Hydrocortisone—psoriasis	4.1e-05	0.000445	CcSEcCtD
Ethinyl Estradiol—Urticaria—Prednisolone—psoriasis	4.08e-05	0.000442	CcSEcCtD
Ethinyl Estradiol—Fatigue—Triamcinolone—psoriasis	4.07e-05	0.000442	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Mycophenolate mofetil—psoriasis	4.05e-05	0.00044	CcSEcCtD
Ethinyl Estradiol—Asthenia—Cyclosporine—psoriasis	4.05e-05	0.000439	CcSEcCtD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.03e-05	0.00209	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—JUN—psoriasis	4.01e-05	0.00208	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	4.01e-05	0.00208	CbGpPWpGaD
Ethinyl Estradiol—Pruritus—Cyclosporine—psoriasis	3.99e-05	0.000433	CcSEcCtD
Ethinyl Estradiol—Urticaria—Hydrocortisone—psoriasis	3.98e-05	0.000432	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Methotrexate—psoriasis	3.98e-05	0.000432	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Methotrexate—psoriasis	3.96e-05	0.00043	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Hydrocortisone—psoriasis	3.96e-05	0.00043	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Hydrocortisone—psoriasis	3.96e-05	0.00043	CcSEcCtD
Ethinyl Estradiol—Asthenia—Mycophenolate mofetil—psoriasis	3.95e-05	0.000428	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—JUN—psoriasis	3.93e-05	0.00204	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—CARM1—psoriasis	3.93e-05	0.00204	CbGpPWpGaD
Ethinyl Estradiol—Pruritus—Mycophenolate mofetil—psoriasis	3.89e-05	0.000422	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Triamcinolone—psoriasis	3.89e-05	0.000422	CcSEcCtD
Ethinyl Estradiol—Anxiety—Prednisone—psoriasis	3.88e-05	0.000421	CcSEcCtD
Ethinyl Estradiol—Alopecia—Methotrexate—psoriasis	3.88e-05	0.000421	CcSEcCtD
Ethinyl Estradiol—ABCB11—Metabolism—NDUFA5—psoriasis	3.87e-05	0.002	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—NFKB1—psoriasis	3.86e-05	0.002	CbGpPWpGaD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	3.86e-05	0.000419	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Cyclosporine—psoriasis	3.86e-05	0.000419	CcSEcCtD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—JUN—psoriasis	3.84e-05	0.00199	CbGpPWpGaD
Ethinyl Estradiol—Discomfort—Prednisone—psoriasis	3.84e-05	0.000417	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Methotrexate—psoriasis	3.84e-05	0.000417	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Methotrexate—psoriasis	3.82e-05	0.000414	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—NFKB1—psoriasis	3.79e-05	0.00196	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Prednisolone—psoriasis	3.78e-05	0.00041	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Mycophenolate mofetil—psoriasis	3.76e-05	0.000409	CcSEcCtD
Ethinyl Estradiol—Urticaria—Triamcinolone—psoriasis	3.75e-05	0.000407	CcSEcCtD
Ethinyl Estradiol—ESR1—LKB1 signaling events—TP53—psoriasis	3.75e-05	0.00194	CbGpPWpGaD
Ethinyl Estradiol—Body temperature increased—Triamcinolone—psoriasis	3.73e-05	0.000405	CcSEcCtD
Ethinyl Estradiol—Dizziness—Cyclosporine—psoriasis	3.73e-05	0.000405	CcSEcCtD
Ethinyl Estradiol—Oedema—Prednisone—psoriasis	3.73e-05	0.000405	CcSEcCtD
Ethinyl Estradiol—Infection—Prednisone—psoriasis	3.7e-05	0.000402	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Betamethasone—psoriasis	3.7e-05	0.000401	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Dexamethasone—psoriasis	3.7e-05	0.000401	CcSEcCtD
Ethinyl Estradiol—Back pain—Methotrexate—psoriasis	3.69e-05	0.000401	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Hydrocortisone—psoriasis	3.69e-05	0.000401	CcSEcCtD
Ethinyl Estradiol—Fatigue—Betamethasone—psoriasis	3.69e-05	0.000401	CcSEcCtD
Ethinyl Estradiol—Fatigue—Dexamethasone—psoriasis	3.69e-05	0.000401	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Prednisone—psoriasis	3.66e-05	0.000397	CcSEcCtD
Ethinyl Estradiol—CYP3A4—Tryptophan metabolism—CAT—psoriasis	3.65e-05	0.00189	CbGpPWpGaD
Ethinyl Estradiol—Dizziness—Mycophenolate mofetil—psoriasis	3.64e-05	0.000395	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL10—psoriasis	3.63e-05	0.00188	CbGpPWpGaD
Ethinyl Estradiol—Skin disorder—Prednisone—psoriasis	3.62e-05	0.000393	CcSEcCtD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.61e-05	0.00187	CbGpPWpGaD
Ethinyl Estradiol—Asthenia—Hydrocortisone—psoriasis	3.6e-05	0.00039	CcSEcCtD
Ethinyl Estradiol—Vomiting—Cyclosporine—psoriasis	3.59e-05	0.000389	CcSEcCtD
Ethinyl Estradiol—Rash—Cyclosporine—psoriasis	3.56e-05	0.000386	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Cyclosporine—psoriasis	3.55e-05	0.000386	CcSEcCtD
Ethinyl Estradiol—Pruritus—Hydrocortisone—psoriasis	3.55e-05	0.000385	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Methotrexate—psoriasis	3.54e-05	0.000385	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL4—psoriasis	3.53e-05	0.00183	CbGpPWpGaD
Ethinyl Estradiol—Headache—Cyclosporine—psoriasis	3.53e-05	0.000383	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Betamethasone—psoriasis	3.53e-05	0.000383	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Dexamethasone—psoriasis	3.53e-05	0.000383	CcSEcCtD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—VEGFA—psoriasis	3.51e-05	0.00182	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal pain—Dexamethasone—psoriasis	3.5e-05	0.00038	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Betamethasone—psoriasis	3.5e-05	0.00038	CcSEcCtD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—NFKB1—psoriasis	3.5e-05	0.00181	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Mycophenolate mofetil—psoriasis	3.5e-05	0.00038	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Triamcinolone—psoriasis	3.48e-05	0.000377	CcSEcCtD
Ethinyl Estradiol—Rash—Mycophenolate mofetil—psoriasis	3.47e-05	0.000376	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Mycophenolate mofetil—psoriasis	3.47e-05	0.000376	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—HLA-B—psoriasis	3.45e-05	0.00179	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	3.45e-05	0.00179	CbGpPWpGaD
Ethinyl Estradiol—Headache—Mycophenolate mofetil—psoriasis	3.45e-05	0.000374	CcSEcCtD
Ethinyl Estradiol—Malaise—Methotrexate—psoriasis	3.44e-05	0.000374	CcSEcCtD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—VDR—psoriasis	3.43e-05	0.00178	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Hydrocortisone—psoriasis	3.43e-05	0.000372	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	3.42e-05	0.00177	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.41e-05	0.00177	CbGpPWpGaD
Ethinyl Estradiol—Urticaria—Betamethasone—psoriasis	3.4e-05	0.000369	CcSEcCtD
Ethinyl Estradiol—Urticaria—Dexamethasone—psoriasis	3.4e-05	0.000369	CcSEcCtD
Ethinyl Estradiol—NR1I2—Generic Transcription Pathway—PPARG—psoriasis	3.4e-05	0.00176	CbGpPWpGaD
Ethinyl Estradiol—Dizziness—Prednisolone—psoriasis	3.39e-05	0.000368	CcSEcCtD
Ethinyl Estradiol—Asthenia—Triamcinolone—psoriasis	3.39e-05	0.000367	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Dexamethasone—psoriasis	3.38e-05	0.000367	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Dexamethasone—psoriasis	3.38e-05	0.000367	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Betamethasone—psoriasis	3.38e-05	0.000367	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Betamethasone—psoriasis	3.38e-05	0.000367	CcSEcCtD
Ethinyl Estradiol—Nausea—Cyclosporine—psoriasis	3.35e-05	0.000364	CcSEcCtD
Ethinyl Estradiol—Pruritus—Triamcinolone—psoriasis	3.34e-05	0.000362	CcSEcCtD
Ethinyl Estradiol—Cough—Methotrexate—psoriasis	3.33e-05	0.000362	CcSEcCtD
Ethinyl Estradiol—Dizziness—Hydrocortisone—psoriasis	3.31e-05	0.00036	CcSEcCtD
Ethinyl Estradiol—ABCB11—Metabolism—CYP2S1—psoriasis	3.29e-05	0.0017	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.29e-05	0.0017	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Mycophenolate mofetil—psoriasis	3.27e-05	0.000355	CcSEcCtD
Ethinyl Estradiol—Rash—Prednisolone—psoriasis	3.24e-05	0.000351	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Prednisolone—psoriasis	3.23e-05	0.000351	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.23e-05	0.00035	CcSEcCtD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	3.22e-05	0.00167	CbGpPWpGaD
Ethinyl Estradiol—Fatigue—Prednisone—psoriasis	3.21e-05	0.000349	CcSEcCtD
Ethinyl Estradiol—Headache—Prednisolone—psoriasis	3.21e-05	0.000349	CcSEcCtD
Ethinyl Estradiol—Discomfort—Methotrexate—psoriasis	3.21e-05	0.000349	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—HLA-A—psoriasis	3.2e-05	0.00166	CbGpPWpGaD
Ethinyl Estradiol—Constipation—Prednisone—psoriasis	3.19e-05	0.000346	CcSEcCtD
Ethinyl Estradiol—Vomiting—Hydrocortisone—psoriasis	3.19e-05	0.000346	CcSEcCtD
Ethinyl Estradiol—Rash—Hydrocortisone—psoriasis	3.16e-05	0.000343	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Hydrocortisone—psoriasis	3.16e-05	0.000343	CcSEcCtD
Ethinyl Estradiol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.15e-05	0.00163	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—STAT3—psoriasis	3.15e-05	0.00163	CbGpPWpGaD
Ethinyl Estradiol—Headache—Hydrocortisone—psoriasis	3.14e-05	0.000341	CcSEcCtD
Ethinyl Estradiol—Dizziness—Triamcinolone—psoriasis	3.12e-05	0.000339	CcSEcCtD
Ethinyl Estradiol—Infection—Methotrexate—psoriasis	3.1e-05	0.000336	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.09e-05	0.0016	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Prednisone—psoriasis	3.07e-05	0.000334	CcSEcCtD
Ethinyl Estradiol—Asthenia—Dexamethasone—psoriasis	3.07e-05	0.000333	CcSEcCtD
Ethinyl Estradiol—Asthenia—Betamethasone—psoriasis	3.07e-05	0.000333	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Methotrexate—psoriasis	3.06e-05	0.000332	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Prednisone—psoriasis	3.05e-05	0.000331	CcSEcCtD
Ethinyl Estradiol—Nausea—Prednisolone—psoriasis	3.05e-05	0.000331	CcSEcCtD
Ethinyl Estradiol—Pruritus—Betamethasone—psoriasis	3.03e-05	0.000329	CcSEcCtD
Ethinyl Estradiol—Pruritus—Dexamethasone—psoriasis	3.03e-05	0.000329	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Methotrexate—psoriasis	3.03e-05	0.000329	CcSEcCtD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—TNF—psoriasis	3.01e-05	0.00156	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Triamcinolone—psoriasis	3e-05	0.000326	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.98e-05	0.00155	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Hydrocortisone—psoriasis	2.98e-05	0.000323	CcSEcCtD
Ethinyl Estradiol—Rash—Triamcinolone—psoriasis	2.98e-05	0.000323	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Triamcinolone—psoriasis	2.97e-05	0.000323	CcSEcCtD
Ethinyl Estradiol—Urticaria—Prednisone—psoriasis	2.96e-05	0.000322	CcSEcCtD
Ethinyl Estradiol—Headache—Triamcinolone—psoriasis	2.96e-05	0.000321	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Prednisone—psoriasis	2.95e-05	0.00032	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Prednisone—psoriasis	2.95e-05	0.00032	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Dexamethasone—psoriasis	2.93e-05	0.000318	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Betamethasone—psoriasis	2.93e-05	0.000318	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	2.92e-05	0.00152	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.92e-05	0.00151	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—CARM1—psoriasis	2.9e-05	0.0015	CbGpPWpGaD
Ethinyl Estradiol—Dizziness—Betamethasone—psoriasis	2.83e-05	0.000307	CcSEcCtD
Ethinyl Estradiol—Dizziness—Dexamethasone—psoriasis	2.83e-05	0.000307	CcSEcCtD
Ethinyl Estradiol—Nausea—Triamcinolone—psoriasis	2.8e-05	0.000304	CcSEcCtD
Ethinyl Estradiol—ESR2—Gene Expression—CARM1—psoriasis	2.77e-05	0.00143	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Prednisone—psoriasis	2.75e-05	0.000298	CcSEcCtD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	2.73e-05	0.00142	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—CARM1—psoriasis	2.72e-05	0.00141	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Betamethasone—psoriasis	2.72e-05	0.000295	CcSEcCtD
Ethinyl Estradiol—Vomiting—Dexamethasone—psoriasis	2.72e-05	0.000295	CcSEcCtD
Ethinyl Estradiol—Rash—Dexamethasone—psoriasis	2.7e-05	0.000293	CcSEcCtD
Ethinyl Estradiol—Rash—Betamethasone—psoriasis	2.7e-05	0.000293	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Dexamethasone—psoriasis	2.7e-05	0.000293	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Betamethasone—psoriasis	2.7e-05	0.000293	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Methotrexate—psoriasis	2.69e-05	0.000292	CcSEcCtD
Ethinyl Estradiol—Fatigue—Methotrexate—psoriasis	2.69e-05	0.000292	CcSEcCtD
Ethinyl Estradiol—Headache—Dexamethasone—psoriasis	2.68e-05	0.000291	CcSEcCtD
Ethinyl Estradiol—Headache—Betamethasone—psoriasis	2.68e-05	0.000291	CcSEcCtD
Ethinyl Estradiol—Asthenia—Prednisone—psoriasis	2.68e-05	0.00029	CcSEcCtD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—IL6—psoriasis	2.66e-05	0.00138	CbGpPWpGaD
Ethinyl Estradiol—Pruritus—Prednisone—psoriasis	2.64e-05	0.000286	CcSEcCtD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	2.61e-05	0.00135	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.6e-05	0.00135	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Methotrexate—psoriasis	2.57e-05	0.000279	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.56e-05	0.00132	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—TYK2—psoriasis	2.55e-05	0.00132	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Prednisone—psoriasis	2.55e-05	0.000277	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Methotrexate—psoriasis	2.55e-05	0.000277	CcSEcCtD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.55e-05	0.00132	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Dexamethasone—psoriasis	2.54e-05	0.000276	CcSEcCtD
Ethinyl Estradiol—Nausea—Betamethasone—psoriasis	2.54e-05	0.000276	CcSEcCtD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—TP53—psoriasis	2.54e-05	0.00131	CbGpPWpGaD
Ethinyl Estradiol—Urticaria—Methotrexate—psoriasis	2.48e-05	0.000269	CcSEcCtD
Ethinyl Estradiol—Dizziness—Prednisone—psoriasis	2.47e-05	0.000268	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Methotrexate—psoriasis	2.46e-05	0.000267	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Methotrexate—psoriasis	2.46e-05	0.000267	CcSEcCtD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—IL6—psoriasis	2.43e-05	0.00126	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—PPARG—psoriasis	2.39e-05	0.00124	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Prednisone—psoriasis	2.37e-05	0.000257	CcSEcCtD
Ethinyl Estradiol—Rash—Prednisone—psoriasis	2.35e-05	0.000255	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Prednisone—psoriasis	2.35e-05	0.000255	CcSEcCtD
Ethinyl Estradiol—NR1I2—Gene Expression—VDR—psoriasis	2.35e-05	0.00122	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—CARM1—psoriasis	2.34e-05	0.00121	CbGpPWpGaD
Ethinyl Estradiol—Headache—Prednisone—psoriasis	2.34e-05	0.000254	CcSEcCtD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—IL6—psoriasis	2.32e-05	0.0012	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Methotrexate—psoriasis	2.3e-05	0.000249	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.25e-05	0.00117	CbGpPWpGaD
Ethinyl Estradiol—Asthenia—Methotrexate—psoriasis	2.24e-05	0.000243	CcSEcCtD
Ethinyl Estradiol—Nausea—Prednisone—psoriasis	2.21e-05	0.00024	CcSEcCtD
Ethinyl Estradiol—Pruritus—Methotrexate—psoriasis	2.2e-05	0.000239	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IFNG—psoriasis	2.14e-05	0.00111	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Methotrexate—psoriasis	2.13e-05	0.000231	CcSEcCtD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.13e-05	0.0011	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	2.08e-05	0.00108	CbGpPWpGaD
Ethinyl Estradiol—Dizziness—Methotrexate—psoriasis	2.06e-05	0.000224	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling Pathways—HCAR2—psoriasis	2.05e-05	0.00106	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	2e-05	0.00104	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.99e-05	0.00103	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Methotrexate—psoriasis	1.98e-05	0.000215	CcSEcCtD
Ethinyl Estradiol—Rash—Methotrexate—psoriasis	1.96e-05	0.000213	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Methotrexate—psoriasis	1.96e-05	0.000213	CcSEcCtD
Ethinyl Estradiol—Headache—Methotrexate—psoriasis	1.95e-05	0.000212	CcSEcCtD
Ethinyl Estradiol—CYP2B6—Metabolism—NDUFA5—psoriasis	1.87e-05	0.000971	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.86e-05	0.000965	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Methotrexate—psoriasis	1.85e-05	0.000201	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.82e-05	0.000941	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TAGAP—psoriasis	1.78e-05	0.000922	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—VDR—psoriasis	1.73e-05	0.000896	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.72e-05	0.000893	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.72e-05	0.000892	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—CAT—psoriasis	1.68e-05	0.000868	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.66e-05	0.000859	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—VDR—psoriasis	1.65e-05	0.000856	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—PPARG—psoriasis	1.64e-05	0.000848	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.64e-05	0.000847	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.61e-05	0.000836	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CARM1—psoriasis	1.61e-05	0.000832	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP2S1—psoriasis	1.59e-05	0.000825	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NDUFA5—psoriasis	1.59e-05	0.000822	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.5e-05	0.000779	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.5e-05	0.000778	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.48e-05	0.000766	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—CAT—psoriasis	1.44e-05	0.000747	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—HLA-A—psoriasis	1.43e-05	0.000742	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—CARM1—psoriasis	1.39e-05	0.000723	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—TNF—psoriasis	1.38e-05	0.000716	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NDUFA5—psoriasis	1.38e-05	0.000716	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.37e-05	0.000712	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	1.37e-05	0.000711	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP2S1—psoriasis	1.35e-05	0.000699	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—APOE—psoriasis	1.34e-05	0.000693	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—APOE—psoriasis	1.3e-05	0.000675	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.29e-05	0.000668	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.28e-05	0.000665	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—IL6—psoriasis	1.25e-05	0.000647	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—NOS2—psoriasis	1.25e-05	0.000645	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.23e-05	0.000635	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—PPARG—psoriasis	1.21e-05	0.000625	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP2S1—psoriasis	1.17e-05	0.000609	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—PPARG—psoriasis	1.15e-05	0.000597	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.14e-05	0.000589	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PPARG—psoriasis	1.13e-05	0.000588	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—APOE—psoriasis	1.12e-05	0.00058	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCL20—psoriasis	1.07e-05	0.000553	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—TYK2—psoriasis	1.02e-05	0.000529	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CAT—psoriasis	9.88e-06	0.000512	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PPARG—psoriasis	9.75e-06	0.000505	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CD4—psoriasis	9.23e-06	0.000478	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	9.11e-06	0.000472	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	8.77e-06	0.000454	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NDUFA5—psoriasis	8.51e-06	0.000441	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—VDR—psoriasis	8.33e-06	0.000431	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	7.96e-06	0.000412	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CARM1—psoriasis	7.78e-06	0.000403	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—APOE—psoriasis	7.67e-06	0.000398	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP2S1—psoriasis	7.24e-06	0.000375	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—STAT3—psoriasis	7.14e-06	0.00037	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.07e-06	0.000366	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	6.82e-06	0.000353	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PPARG—psoriasis	6.68e-06	0.000346	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CARM1—psoriasis	6.59e-06	0.000341	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.16e-06	0.000319	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	6.01e-06	0.000312	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SOCS1—psoriasis	5.87e-06	0.000304	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PPARG—psoriasis	5.81e-06	0.000301	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CARM1—psoriasis	5.74e-06	0.000297	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—IL6—psoriasis	4.99e-06	0.000259	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CAT—psoriasis	4.79e-06	0.000248	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—LEP—psoriasis	4.33e-06	0.000225	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—APOE—psoriasis	4.33e-06	0.000225	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CAT—psoriasis	4.05e-06	0.00021	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NFKBIA—psoriasis	4.04e-06	0.000209	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—APOE—psoriasis	3.72e-06	0.000193	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CARM1—psoriasis	3.54e-06	0.000183	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CAT—psoriasis	3.53e-06	0.000183	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TYK2—psoriasis	3.31e-06	0.000171	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PPARG—psoriasis	3.24e-06	0.000168	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—APOE—psoriasis	3.15e-06	0.000163	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CXCL8—psoriasis	2.88e-06	0.000149	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—APOE—psoriasis	2.74e-06	0.000142	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PPARG—psoriasis	2.74e-06	0.000142	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—JUN—psoriasis	2.68e-06	0.000139	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NFKB1—psoriasis	2.58e-06	0.000134	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PPARG—psoriasis	2.39e-06	0.000124	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—VEGFA—psoriasis	2.34e-06	0.000121	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—STAT3—psoriasis	2.32e-06	0.00012	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CAT—psoriasis	2.17e-06	0.000113	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TP53—psoriasis	1.77e-06	9.16e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—APOE—psoriasis	1.69e-06	8.75e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL6—psoriasis	1.62e-06	8.38e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PPARG—psoriasis	1.47e-06	7.62e-05	CbGpPWpGaD
